Clinical trial NCT01471483: Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Official title: Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer
Keywords: Geriatric Assessment
Quality of Life
11-164
Fallopian Tubes
Lead sponsor: Memorial Sloan Kettering Cancer Center
Sponsor class: OTHER
First posted: 2011-11-15
Enrollment: 50
Sex: FEMALE
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: The MSKCC Gynecologic clinic

Brief summary: Older woman with ovarian cancer have a worse prognosis compared to younger patients. However, the reason is not known. Currently, the standard of care is to evaluate younger and older patients with cancer the same way. However, older patients with cancer often have more complicated issues to manage. For example, older patients often have other medical problems, take more medications, and be dependent on others for help and transportation. Too often, the medical team is unaware of these issues which can effect the patients care.

The purpose of this study is to apply a set of questions designed specifically for patients with cancer who are older than 65 years of age. These questions are called a geriatric assessment.

The investigators want to better understand which older patients with ovarian cancer will be able to tolerate the chemotherapy and surgery and why. This study will also see if a telephone call from a nurse who specializes in caring for older patients will improve patient care. This study will determine how feasible it is to perform geriatric assessments and telephone calls in patients with ovarian cancer.


Eligibility criteria: Inclusion Criteria:

* Patients must be \> or = to age of 65. Will receive platinum-based chemotherapy and surgery at MSKCC for stage II-IV ovarian, fallopian tube or peritoneal cancer.
* Pathologic confirmation or high suspicion based on Ca125 level and/or radiologic evidence of ovarian, fallopian tube or peritoneal cancer.
* Able to understand English.
* Be able to provide informed consent.

Exclusion Criteria:

* Enrolled on a phase I trial.

Primary outcomes:
measure: feasibility of a geriatric assessment (GA)
timeFrame: 2 years
measure: feasibility of a weekly geriatric nursing telephone intervention
timeFrame: 2 years
Secondary outcomes:
measure: estimate if the cancer-specific GA parameters will predict toxicity.
timeFrame: 2 years
measure: differences in the surgical and chemotherapy toxicity
timeFrame: 2 years
Other outcomes:
Locations:
city: Commack
country: United States
facility: Memorial Sloan-Kettering Cancer Center @ Suffolk
state: New York
city: Commack
country: United States
facility: Memorial Sloan-Kettering Cancer Center at Commack
state: New York
city: New York
country: United States
facility: Memorial Sloan-Kettering Cancer Center
state: New York
Study officials:
affiliation: Memorial Sloan Kettering Cancer Center
name: William Tew, MD
role: PRINCIPAL_INVESTIGATOR
References: